A randomized, multicenter, pilot study comparing the efficacy and safety of a bupivacaine-collagen implant (XaraColl(®)) with the ON-Q PainBuster(®) Post-op Pain Relief System foll...

por Cusack, Susan L, Minkowitz, Harold S, Kuss, Michael, Jaros, Mark, Hemsen, Lisa
Publicado 2012

Arbaclofen extended-release tablets for spasticity in multiple sclerosis: randomized, controlled clinical trial

por Okuda, Darin T, Kantor, Daniel, Jaros, Mark, deVries, Tina, Hunter, Samuel
Publicado 2022

Arbaclofen extended-release tablets for spasticity in multiple sclerosis: open-label extension study

por Okuda, Darin T, Kantor, Daniel, Jaros, Mark, deVries, Tina, Hunter, Samuel
Publicado 2023

Clinical evaluation of XaraColl(®), a bupivacaine-collagen implant, for postoperative analgesia in two multicenter, randomized, double-blind, placebo-controlled pilot studies

por Cusack, Susan L, Jaros, Mark, Kuss, Michael, Minkowitz, Harold S, Winkle, Peter, Hemsen, Lisa
Publicado 2012

Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 random...

por Ondo, William G, Hermanowicz, Neal, Borreguero, Diego García, Jaros, Mark J, Kim, Richard, Shang, Gwendoline
Publicado 2015

Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials

por Slonim, Charles B., Foster, Shane, Jaros, Mark, Kannarr, Shane R., Korenfeld, Michael S., Smyth-Medina, Robert, Wirta, David L.
Publicado 2020

Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results

por Bacharach, Jason, Wirta, David L, Smyth-Medina, Robert, Korenfeld, Michael S, Kannarr, Shane R, Foster, Shane, J Jaros, Mark, Slonim, Charles B
Publicado 2021

Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials

por Wirta, David L, Korenfeld, Michael S, Foster, Shane, Smyth-Medina, Robert, Bacharach, Jason, Kannarr, Shane R, Jaros, Mark J, Slonim, Charles B
Publicado 2021

CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective Registry

por Song, Tae, Hayanga, Jeremiah, Durham, Lucian, Garrison, Lawrence, McCarthy, Paul, Barksdale, Andy, Smith, Deane, Bartlett, Robert, Jaros, Mark, Nelson, Peter, Molnar, Zsolt, Deliargyris, Efthymios, Moazami, Nader
Publicado 2021

Effect of inclisiran on lipids in primary prevention: the ORION-11 trial

por Ray, Kausik K, Kallend, David, Leiter, Lawrence A, Raal, Frederick J, Koenig, Wolfgang, Jaros, Mark J, Schwartz, Gregory G, Landmesser, Ulf, Garcia Conde, Lorena, Wright, R Scott
Publicado 2022

Inclisiran and cardiovascular events: a patient-level analysis of phase III trials

por Ray, Kausik K, Raal, Frederick J, Kallend, David G, Jaros, Mark J, Koenig, Wolfgang, Leiter, Lawrence A, Landmesser, Ulf, Schwartz, Gregory G, Lawrence, David, Friedman, Andrew, Garcia Conde, Lorena, Wright, R Scott
Publicado 2022

NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis

por Harrison, Stephen A., Rossi, Stephen J., Paredes, Angelo H., Trotter, James F., Bashir, Mustafa R., Guy, Cynthia D., Banerjee, Rajarshi, Jaros, Mark J., Owers, Sandra, Baxter, Bryan A., Ling, Lei, DePaoli, Alex M.
Publicado 2019

Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study

por Smith, Edward C., Conklin, Laurie S., Hoffman, Eric P., Clemens, Paula R., Mah, Jean K., Finkel, Richard S., Guglieri, Michela, Tulinius, Mar, Nevo, Yoram, Ryan, Monique M., Webster, Richard, Castro, Diana, Kuntz, Nancy L., Kerchner, Laurie, Morgenroth, Lauren P., Arrieta, Adrienne, Shimony, Maya, Jaros, Mark, Shale, Phil, Gordish-Dressman, Heather, Hagerty, Laura, Dang, Utkarsh J., Damsker, Jesse M., Schwartz, Benjamin D., Mengle-Gaw, Laurel J., McDonald, Craig M.
Publicado 2020

Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

por Hoffman, Eric P., Schwartz, Benjamin D., Mengle-Gaw, Laurel J., Smith, Edward C., Castro, Diana, Mah, Jean K., McDonald, Craig M., Kuntz, Nancy L., Finkel, Richard S., Guglieri, Michela, Bushby, Katharine, Tulinius, Mar, Nevo, Yoram, Ryan, Monique M., Webster, Richard, Smith, Andrea L., Morgenroth, Lauren P., Arrieta, Adrienne, Shimony, Maya, Siener, Catherine, Jaros, Mark, Shale, Phil, McCall, John M., Nagaraju, Kanneboyina, van den Anker, John, Conklin, Laurie S., Cnaan, Avital, Gordish-Dressman, Heather, Damsker, Jesse M., Clemens, Paula R.
Publicado 2019

Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial

por Guglieri, Michela, Clemens, Paula R., Perlman, Seth J., Smith, Edward C., Horrocks, Iain, Finkel, Richard S., Mah, Jean K., Deconinck, Nicolas, Goemans, Nathalie, Haberlova, Jana, Straub, Volker, Mengle-Gaw, Laurel J., Schwartz, Benjamin D., Harper, Amy D., Shieh, Perry B., De Waele, Liesbeth, Castro, Diana, Yang, Michelle L., Ryan, Monique M., McDonald, Craig M., Tulinius, Mar, Webster, Richard, McMillan, Hugh J., Kuntz, Nancy L., Rao, Vashmi K., Baranello, Giovanni, Spinty, Stefan, Childs, Anne-Marie, Sbrocchi, Annie M., Selby, Kathryn A., Monduy, Migvis, Nevo, Yoram, Vilchez-Padilla, Juan J., Nascimento-Osorio, Andres, Niks, Erik H., de Groot, Imelda J.M., Katsalouli, Marina, James, Meredith K., van den Anker, Johannes, Damsker, Jesse M., Ahmet, Alexandra, Ward, Leanne M., Jaros, Mark, Shale, Phil, Dang, Utkarsh J., Hoffman, Eric P.
Publicado 2022